HUP0200325A2 - Pharmaceutical composition containing proton pump inhibitors - Google Patents

Pharmaceutical composition containing proton pump inhibitors

Info

Publication number
HUP0200325A2
HUP0200325A2 HU0200325A HUP0200325A HUP0200325A2 HU P0200325 A2 HUP0200325 A2 HU P0200325A2 HU 0200325 A HU0200325 A HU 0200325A HU P0200325 A HUP0200325 A HU P0200325A HU P0200325 A2 HUP0200325 A2 HU P0200325A2
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
composition containing
proton pump
pump inhibitors
containing proton
Prior art date
Application number
HU0200325A
Other languages
English (en)
Inventor
Keith Freehauf
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of HUP0200325A2 publication Critical patent/HUP0200325A2/hu
Publication of HUP0200325A3 publication Critical patent/HUP0200325A3/hu
Publication of HU228181B1 publication Critical patent/HU228181B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0200325A 1999-02-23 2000-02-18 Pharmaceutical composition containing proton pump inhibitors HU228181B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12125399P 1999-02-23 1999-02-23
PCT/US2000/004170 WO2000050038A1 (en) 1999-02-23 2000-02-18 Pharmaceutical composition containing proton pump inhibitors

Publications (3)

Publication Number Publication Date
HUP0200325A2 true HUP0200325A2 (en) 2002-06-29
HUP0200325A3 HUP0200325A3 (en) 2003-05-28
HU228181B1 HU228181B1 (en) 2013-01-28

Family

ID=22395498

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200325A HU228181B1 (en) 1999-02-23 2000-02-18 Pharmaceutical composition containing proton pump inhibitors

Country Status (31)

Country Link
US (1) US6316481B1 (hu)
EP (1) EP1156806B1 (hu)
JP (1) JP2002537337A (hu)
KR (1) KR100701448B1 (hu)
CN (1) CN1227009C (hu)
AR (1) AR029615A1 (hu)
AT (1) ATE263562T1 (hu)
AU (1) AU771061B2 (hu)
BG (1) BG65291B1 (hu)
BR (1) BR0008403A (hu)
CA (1) CA2362932C (hu)
CO (1) CO5140102A1 (hu)
CZ (1) CZ301647B6 (hu)
DE (1) DE60009675T2 (hu)
DK (1) DK1156806T3 (hu)
EA (1) EA004683B1 (hu)
ES (1) ES2216870T3 (hu)
HK (1) HK1041650A1 (hu)
HR (1) HRP20010615B1 (hu)
HU (1) HU228181B1 (hu)
IL (1) IL144131A0 (hu)
ME (1) ME00864B (hu)
NO (1) NO328863B1 (hu)
NZ (1) NZ512771A (hu)
PL (1) PL195783B1 (hu)
PT (1) PT1156806E (hu)
RS (1) RS50023B (hu)
SK (1) SK286371B6 (hu)
TW (1) TW587936B (hu)
WO (1) WO2000050038A1 (hu)
ZA (1) ZA200106104B (hu)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
WO2001091748A2 (en) * 2000-05-30 2001-12-06 Merial Limited Methods for prevention of ulcers and improving physiological performance
US7988999B2 (en) 2000-12-07 2011-08-02 Nycomed Gmbh Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
DE10061135C1 (de) * 2000-12-07 2002-11-07 Byk Gulden Lomberg Chem Fab Pharmazeutische Zubereitung in Form einer Paste enthaltend einen säurelabilen Wirkstoff
KR20030059318A (ko) 2000-12-07 2003-07-07 알타나 파마 아게 산 불안정성 활성 성분을 포함하는 현탁액 형태의 약학 제제
EP1534278A4 (en) 2002-08-01 2006-09-06 Nitromed Inc NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD
GB2394895A (en) * 2002-11-06 2004-05-12 Cipla Ltd Proton pump inhibitor composition in paste form
WO2005000269A1 (en) * 2003-06-26 2005-01-06 Cipla Limited Pharmaceutical formulations comprising a proton pump inhibitor
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2006026829A1 (en) * 2004-09-09 2006-03-16 Metelli Pty Ltd Stable paste composition of enteric coated acid labile active agent and use thereof
CN101500553B (zh) * 2006-07-25 2012-04-18 维克塔有限公司 联合使用小分子二羧酸的衍生物与ppi用于抑制胃酸分泌的组合物和方法
AU2008215659B2 (en) 2007-02-16 2012-11-01 Aska Pharmaceutical Co., Ltd. Pharmaceutical composition comprising microparticle oily suspension
AU2010276404A1 (en) 2009-07-20 2012-02-02 Vetegen, Llc A stable pharmaceutical omeprazole formulation for oral administration
US8722636B2 (en) 2011-01-31 2014-05-13 New Market Pharmaceuticals, LLC Animal treatments
US10064849B2 (en) 2012-05-02 2018-09-04 New Market Pharmaceuticals Pharmaceutical compositions for direct systemic introduction
CA2872396C (en) 2012-05-02 2022-12-13 Newmarket Pharmaceuticals Llc Pharmaceutical compositions for direct systemic introduction comprising a proton pump inhibitor
GB2524351B (en) * 2013-10-18 2016-12-14 Norbrook Lab Ltd Proton Pump Inhibitor Paste Compositions
WO2015055974A1 (en) * 2013-10-18 2015-04-23 Norbrook Laboratories Limited Proton pump inhibitor paste compositions
EP3386507B1 (en) 2015-12-08 2023-06-07 Luoda Pharma Limited Methods and compositions for treating gastric ulcers
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS
ES2723873B1 (es) * 2018-03-01 2020-05-13 Hernan Ma Carmen Batanero Medicamento combinado con omeprazol y vitamina B12
CN112972481A (zh) * 2021-03-18 2021-06-18 华农（肇庆）生物产业技术研究院有限公司 药物组合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255432A (en) 1979-09-06 1981-03-10 Syntex (U.S.A.) Inc. 8-[2-3-Indolyl)ethyl]-1-oxa-3-,8-diazaspiro[4.5]decan-2-ones, pharmaceutical compositions thereof and methods of use thereof
DK130287D0 (da) 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
SE9301489D0 (sv) 1993-04-30 1993-04-30 Ab Astra Veterinary composition
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors

Also Published As

Publication number Publication date
EA200100905A1 (ru) 2002-02-28
YU50401A (sh) 2004-05-12
NO20014074D0 (no) 2001-08-22
CN1227009C (zh) 2005-11-16
PL195783B1 (pl) 2007-10-31
HU228181B1 (en) 2013-01-28
EP1156806B1 (en) 2004-04-07
BG65291B1 (bg) 2007-12-28
RS50023B (sr) 2008-09-29
CO5140102A1 (es) 2002-03-22
WO2000050038A1 (en) 2000-08-31
CA2362932A1 (en) 2000-08-31
BG105754A (en) 2002-03-29
US6316481B1 (en) 2001-11-13
CA2362932C (en) 2010-11-30
AU3368700A (en) 2000-09-14
CZ20013058A3 (cs) 2001-11-14
PT1156806E (pt) 2004-07-30
NO328863B1 (no) 2010-05-31
KR100701448B1 (ko) 2007-03-30
HRP20010615B1 (en) 2011-03-31
PL350729A1 (en) 2003-01-27
HRP20010615A2 (en) 2002-12-31
NO20014074L (no) 2001-08-22
DK1156806T3 (da) 2004-08-02
EA004683B1 (ru) 2004-06-24
SK286371B6 (sk) 2008-08-05
SK12062001A3 (sk) 2001-12-03
BR0008403A (pt) 2002-01-29
KR20010102297A (ko) 2001-11-15
CN1341022A (zh) 2002-03-20
JP2002537337A (ja) 2002-11-05
DE60009675D1 (de) 2004-05-13
HK1041650A1 (en) 2002-07-19
AR029615A1 (es) 2003-07-10
AU771061B2 (en) 2004-03-11
ZA200106104B (en) 2002-12-24
DE60009675T2 (de) 2005-03-24
HUP0200325A3 (en) 2003-05-28
NZ512771A (en) 2003-02-28
IL144131A0 (en) 2002-05-23
ATE263562T1 (de) 2004-04-15
TW587936B (en) 2004-05-21
EP1156806A1 (en) 2001-11-28
CZ301647B6 (cs) 2010-05-12
ES2216870T3 (es) 2004-11-01
ME00864B (me) 2008-09-29

Similar Documents

Publication Publication Date Title
HUP0200325A2 (en) Pharmaceutical composition containing proton pump inhibitors
HUP9801626A3 (en) Pharmaceutical composition containing proton pump inhibitors
HK1045650B (zh) 藥物組合物
IL147970A0 (en) Pharmaceutical compositions containing tripeptides
IL147778A0 (en) Pharmaceutical compositions containing cyclobenzaprine
PL355330A1 (en) Pharmaceutical compositions
GB9923436D0 (en) Pharmaceutical compositions
HUP0001632A3 (en) Pharmaceutical compositions comprising selective phosphodiestherase inhibitors
IL150062A0 (en) Proton pump inhibitors
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
GB9904163D0 (en) Pharmaceutical compositions
HUP0003836A3 (en) Pharmaceutical compositions containing lasofoxifene
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
GB9911017D0 (en) Pharmaceutical compositions
GB9904911D0 (en) Pharmaceutical compositions
IL149470A0 (en) Pharmaceutical compositions containing carboxamidoadenosine derivatives
SI1156806T1 (en) Pharmaceutical composition containing proton pump inhibitors
HUP0004454A3 (en) Pharmaceutical compositions as apo b secretion/mtp inhibitors
GB9926251D0 (en) Pharmaceutical formulation
PL350899A1 (en) Pharmaceutical composition based on polyaromatic compounds
HU9900587D0 (en) New pharmaceutical composition
GB9916210D0 (en) Pharmaceutical composition
ZA200100696B (en) Pharmaceutical compositions containing lipase inhibitors
GB9909073D0 (en) Novel pharmaceutical composition
GB9909297D0 (en) Novel pharmaceutical composition

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: MERCK SHARP & DOHME CORP., US

Free format text: FORMER OWNER(S): MERCK & CO., INC., US

GB9A Succession in title

Owner name: MERCK SHARP & DOHME CORP., US

Free format text: FORMER OWNER(S): MERCK & CO., INC., US; MERCK SHARP & DOHME CORP., US; SCHERING CORPORATION, US

HC9A Change of name, address

Owner name: MERCK SHARP & DOHME CORP., US

Free format text: FORMER OWNER(S): MERCK & CO., INC., US; MERCK SHARP & DOHME CORP., US; SCHERING CORPORATION, US